Gujarat Kidney And Super Speciality enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026
1,403—
13.313.3
2.22.2
15.715.7
1,408—
2.42.4
₹178.58—
270270
5.8%5.8%
0.01×—
13.93×—
52.75×—
65.43×—
Reference items — trailing FY values
10182.0
26.726.9
21.522.2
—−3.9
−14.7−14.7
—−15.1
—10.8
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

GKSL₹177.99

Gujarat Kidney And Super Speciality Limited

· Pharma & Health
₹ CrorePeersGPTHEALTHSHALBYINDRAMEDCOLOTUSEYEARTEMISMEDDRAGARWQKMCSHILKOVAIMcap ₹1,403 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization—1,403.3
- Cash, Equiv & ST Investments13.313.3
+ Minority Interest2.22.2
+ Total Debt15.715.7
Enterprise Value—1,408.0
Net Debt (memo)2.42.4
EV per Share—178.58
Total Capital270.5270.5
Total Debt/Total Capital5.815.81
Total Debt/EV—0.01
EV/Sales—13.93
EV/EBITDA—52.75
EV/EBIT—65.43
Reference Items — Trailing FY Values
Sales82.0101.0
EBITDA26.926.7
EBIT22.221.5
Operating Cash Flow-3.9—
Free Cash Flow-14.7-14.7
FCFF (free cash flow to the firm)-15.1—
Capital Expenditure10.8—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.